Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Miyatani Y, Choi D, Choi NK, Rubin DT, et al. Dig Dis Sci 2023 Dec 19. doi: 10.1007/s10620-023-08182.

Read + Share

Amedeo Smart

Independent Medical Education

Miyatani Y, Choi D, Choi NK, Rubin DT, et al. Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Dig Dis Sci 2023 Dec 19. doi: 10.1007/s10620-023-08182.
PMID: 38112840